Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab

BACKGROUND: We have previously investigated neoadjuvant ipilimumab (ipi) for patients with locally/regionally advanced melanoma. That initial assessment of peripheral blood mononuclear cells (PBMC) showed a significant increase in shared tumor associated antigen specific CD4(+) and CD8(+) T cell act...

Descripción completa

Detalles Bibliográficos
Autores principales: Retseck, Janet, VanderWeele, Robert, Lin, Hui-Min, Lin, Yan, Butterfield, Lisa H., Tarhini, Ahmad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915044/
https://www.ncbi.nlm.nih.gov/pubmed/27330811
http://dx.doi.org/10.1186/s40425-016-0141-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915044/
https://www.ncbi.nlm.nih.gov/pubmed/27330811
http://dx.doi.org/10.1186/s40425-016-0141-1

Ejemplares similares